Gram-positiveCocciCatalase-negative

Streptococcus agalactiae

Encapsulated beta-hemolytic Group B Streptococcus (Gram-positive coccus in chains) that is a leading cause of neonatal meningitis, sepsis, and pneumonia, as well as invasive infections in pregnant women and immunocompromised adults.

Organism Card

DomainMust know
Identity
  • Group B Streptococcus (GBS) = Streptococcus agalactiae [1][2][3]
  • Gram-positive cocci in chains
  • Lancefield group B antigen
  • Normal flora of lower female genital tract and GI tract [2]
Lab discriminator
  • β-haemolytic on blood agar
  • CAMP test positive (arrow-head haemolysis with S. aureus)
  • Hippurate hydrolysis positive (vs other β-haemolytic strep)
  • Bacitracin resistant (vs GAS which is bacitracin sensitive)
  • Catalase negative (vs staphylococci)
Reservoir / transmission
  • Normal flora of lower female genital tract → vertical transmission during delivery [2]
  • Colonises ~10–30% of pregnant women (vaginal/rectal)
  • Screen by low vaginal swab at 35–37 weeks gestation [2][7]
  • Also colonises GI tract → source for UTI in adults
Key virulence
  • Polysaccharide capsule (types Ia, Ib, II, III, V) → anti-phagocytic; type III strongly a/w neonatal meningitis
  • β-haemolysin/cytolysin → lung epithelial injury
  • C5a peptidase → impairs neutrophil recruitment
  • Sialic acid capsule → molecular mimicry, evades complement
Clinical syndromes
  • Neonatal sepsis (early-onset < 7 days; late-onset 7–90 days) [2][3][4]
  • Neonatal meningitis (top cause in neonates < 1 month, also 1–3 months) [4]
  • UTI (esp. in pregnant women, elderly, diabetics) [2][6]
  • Subacute bacterial endocarditis (penicillin-sensitive; friable vegetations) [2][5]
  • Chorioamnionitis, puerperal sepsis
  • Pneumonia in neonates and elderly
  • Meningitis in adults > 50 years and immunocompromised [4]
Diagnosis
  • Gram stain of CSF: Gram-positive cocci in chains in a neonate → think GBS [3][7]
  • Blood culture / CSF culture: definitive
  • Prenatal screening: low vaginal + rectal swab at 35–37 weeks for culture [2][7]
  • Rapid antigen detection (latex agglutination) on CSF — adjunct
  • Pitfall: culture may be negative if intrapartum antibiotics already given
Treatment
  • Penicillin G (benzylpenicillin) is first-line for all GBS infections [2][5][7]
  • Intrapartum antibiotic prophylaxis (IAP): IV benzylpenicillin given to GBS-colonised mothers in labour [7]
  • Ampicillin is alternative for IAP
  • If penicillin allergy: clindamycin or vancomycin (check susceptibility)
  • Meningitis Tx duration: 14–21 days [4]
  • IE: penicillin G ± gentamicin for synergy [5]
  • GBS remains universally penicillin-susceptible (no penicillin resistance reported)
Prevention
  • Universal antenatal GBS screening at 35–37 weeks gestation [2][7]
  • IAP with IV benzylpenicillin if screen positive, to prevent early-onset neonatal disease [7]
  • IAP also indicated if: previous infant with GBS disease, GBS bacteriuria in current pregnancy, unknown GBS status with risk factors (preterm < 37 wk, ROM ≥ 18 h, intrapartum fever ≥ 38°C)
  • No licensed GBS vaccine currently (research ongoing)
  • Not a notifiable disease in HK
Classic traps
  • GBS ≠ GAS: GBS causes neonatal disease; GAS causes rheumatic fever / scarlet fever / pharyngitis [2]
  • Day-2 neonate with fever + Gram-positive cocci in chains on CSF Gram stain → GBS, not pneumococcus or Enterococcus [3][7]
  • GBS is bacitracin-resistant and CAMP-positive; GAS is bacitracin-sensitive and CAMP-negative
  • GBS IE is treated with penicillin (like viridans strep); Enterococcal IE needs aminoglycoside addition due to intrinsic cephalosporin resistance [5]
  • UTI isolate of GBS in a woman of childbearing age → flag for antenatal implications

Exam Intelligence

On this page

No Headings